As is illustrated in liver cancer, A-to-I RNA editing of AZIN1 may facilitate tumorigenesis through neutralizing antizyme mediated degradation of ODC and cyclin D. Furthermore, the nuclear translocation of RNA-edited AZIN1 is required for increased tumor aggressiveness. This evidence concerns the gene AZIN1 and neoplasm.